Byrne Asset Management LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 202 filers reported holding PTC THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
Byrne Asset Management LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,000
+55455.6%
6750.0%0.01%
-33.3%
Q2 2023$27
-18.2%
6750.0%0.02%
-25.0%
Q1 2023$33
-99.8%
675
+28.6%
0.02%
+60.0%
Q4 2022$20,039
-22.9%
5250.0%0.02%
-25.0%
Q3 2022$26,000
+23.8%
5250.0%0.02%
+25.0%
Q2 2022$21,000
+5.0%
5250.0%0.02%
+33.3%
Q1 2022$20,000
-4.8%
5250.0%0.01%
-14.3%
Q4 2021$21,0005250.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Burrage Capital Management LLC 160,372$7,594,0006.15%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 408,000$19,319,0005.11%
RTW INVESTMENTS, LP 5,293,966$250,669,0003.91%
GEORGE KAISER FAMILY FOUNDATION 72,105$9,925,0002.07%
SECTORAL ASSET MANAGEMENT INC 504,928$23,908,0001.81%
Redwood Investments, LLC 385,014$18,230,0001.60%
ARMISTICE CAPITAL, LLC 1,396,000$66,101,0001.52%
Integral Health Asset Management, LLC 100,100$4,740,0001.35%
Sofinnova Investments, Inc. 466,840$22,105,0001.33%
Chubb Ltd 8,180$387,0001.10%
View complete list of PTC THERAPEUTICS INC shareholders